Catalyst Wire Dossier Catalyst Wire Dossier

Olanzapine Glenmark Europe

olanzapine · Glenmark Arzneimittel GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Olanzapine Glenmark Europe, covering 2022-12-20 to 2022-12-20. Get the full timeline:

Most recent: EMA Authorised: Olanzapine Glenmark Europe (olanzapine) — Glenmark Arzneimittel GmbH

See pricing